Business Context and Reporting Period
The filing is a Form 10-K for Bioflamex Corporation, formerly Deer Bay Resources Inc., a Nevada development-stage company focused on biological, water-based fire extinguishing and fire-prevention products. The reported fiscal year ended February 29, 2012, with comparison to February 28, 2011. The request metadata identifies Cann American Corp. and “2010 Q4,” which does not match the filing text.
The company acquired fire-product intellectual property on January 25, 2011, and had not generated revenue or commenced significant operations through fiscal 2012. Its principal planned product is the Bioflamex aerosol extinguisher, supported by planned bulk extinguishers, fire retardants, forest-fire solutions, and PurifyAir smoke hoods.
Key Financial Metrics
| Metric | Year ended February 29, 2012 | Year ended February 28, 2011 |
|---|---|---|
| Revenue | $0 | $0 |
| Operating expenses | $257,872 | $45,377 |
| Net loss | $264,581 | $45,377 |
| Net loss per share | $0.00 basic and diluted | $0.00 basic and diluted |
| Cash flow used in operations | $53,902 | $50,037 |
| Cash flow from financing | $54,034 | $50,000 |
| Cash and cash equivalents | $191 | $59 |
| Total assets | $1,191,191 | $1,201,059 |
| Current liabilities | $243,555 | $68,840 |
| Working capital | Deficit of $243,364 | Not clearly provided |
| Accumulated deficit | $399,164 | $134,583 |
Intangible assets, consisting of patents and trademarks acquired in 2011, were recorded at $1,191,000 and represented virtually all company assets. The filing does not provide a meaningful operating margin because the company had no revenue.
Current liabilities included $159,589 of accounts payable and accrued expenses, $12,385 of related-party accrued expenses, $7,047 of accrued interest, a $4,034 related-party note, and a $60,500 convertible debenture. The related-party note bears 15% interest, is callable, matured December 31, 2012, and was stated to be in default.
Material Changes Versus the Prior Comparable Period
- Operating expenses increased by $212,495, or approximately 468%, primarily because of $152,979 in consulting fees and $30,000 in compensation expense that were not incurred in fiscal 2011.
- Net loss increased by $219,204, or approximately 483%, to $264,581.
- Operating cash use increased modestly from $50,037 to $53,902, while accounts payable and accrued expenses increased substantially.
- Current liabilities increased from $68,840 to $243,555, producing a $243,364 working-capital deficit.
- The company issued 333,334 shares for $50,000 in cash and 200,000 shares for $30,000 of services during fiscal 2012.
- Shares outstanding increased from 92,466,667 at February 28, 2011 to 93,000,001 at February 29, 2012. Subsequent issuances increased reported shares outstanding to 150,550,121 by May 24, 2012.
Guidance, Outlook, Risks, and Unusual Items
- Management planned to begin production and market penetration for Bioflamex aerosols during 2012 and 2013, with a targeted U.S. launch in the third or fourth quarter of 2012.
- UL, DIN, TÜV, NFPA, EN3, and other market-specific approvals were still pending or in process. These certifications were necessary for planned sales in the United States, Europe, and other markets.
- Key supplier and production agreements with Hartindo Saudi and Dansoll A/S were described inconsistently as drafted, pending finalization, or in place. Their definitive status should be verified.
- The company stated that it required a cash injection of approximately $2 million to begin operations, fund marketing, manufacture and deliver products, and generate revenue.
- After year-end, the company entered an agreement with Dutchess Opportunity Fund II, LP, providing a potential equity line of up to $10 million over 36 months, subject to conditions including an effective registration statement. The facility could result in substantial equity issuance and dilution.
- Management stated that available cash was insufficient to operate for the next twelve months and that substantial doubt existed regarding the company’s ability to continue as a going concern. Management expected continued losses and did not expect near-term profitability.
- The company reported material weaknesses in internal control over financial reporting: inadequate segregation of duties and risk assessment, and insufficient written accounting and financial-reporting policies. Disclosure controls were deemed ineffective as of February 29, 2012.
- The Sentinel forest-fire detection and suppression project was delayed following the death of a key development partner. Alternative partners were being evaluated, and patent filing was deferred to late 2012 or early 2013.
- The intellectual property asset was acquired in a related-party, non-cash transaction for 38 million shares valued at $1,191,000. Its recoverability depends on successful commercialization, certifications, financing, and market adoption.
- The company traded on the OTC Bulletin Board and was subject to penny-stock trading restrictions, which could limit liquidity. No dividends were planned.
Important Facts to Verify
- Confirm the correct issuer and reporting period, because the supplied metadata does not match the filing.
- Verify the final execution and exclusivity terms of the Hartindo Saudi and Dansoll agreements.
- Verify whether the Dutchess equity line registration statement became effective and how many shares were subsequently issued.
- Assess the valuation and impairment risk of the $1.191 million patents-and-trademarks asset.
- Confirm the default status, maturity, conversion terms, and potential dilution associated with the $60,500 convertible debenture and related-party note.
- Determine whether required UL, DIN, TÜV, NFPA, EN3, and forest-fire certifications were obtained and whether commercial sales actually commenced.
- Review the going-concern disclosure, financing needs, liquidity runway, and progress in remediating internal-control weaknesses.